Franklin Street Advisors Inc Intra Cellular Therapies, Inc. Transaction History

Franklin Street Advisors Inc

$1.4 Billion
Q2 2024

A detailed history of Franklin Street Advisors Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Franklin Street Advisors Inc holds 10,783 shares of ITCI stock, worth $780,904. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,783

Previous 13,783 21.77%

Holding current value

$780,904

Previous $954,000 22.54%

% of portfolio

0.05%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$64.76 - $79.84 $194,280 - $239,520	-3,000 Reduced 21.77%	10,783 $739,000
Q3 2023 Oct 10, 2023	SELL	$52.09 - $64.1 $3,906 - $4,807	-75 Reduced 0.54%	13,783 $718,000
Q1 2023 Apr 12, 2023	SELL	$43.8 - $56.99 $6,570 - $8,548	-150 Reduced 1.07%	13,858 $750,000
Q3 2022 Oct 11, 2022	SELL	$42.7 - $59.99 $106,750 - $149,975	-2,500 Reduced 15.14%	14,008 $652,000
Q2 2022 Jul 13, 2022	SELL	$43.0 - $65.64 $230,050 - $351,174	-5,350 Reduced 24.48%	16,508 $942,000
Q1 2022 Apr 18, 2022	SELL	$38.74 - $62.09 $544,297 - $872,364	-14,050 Reduced 39.13%	21,858 $1.34 Million
Q4 2021 Jan 26, 2022	BUY	$35.2 - $53.42 $111,584 - $169,341	3,170 Added 9.68%	35,908 $1.88 Million
Q3 2021 Oct 22, 2021	SELL	$28.72 - $42.49 $574,400 - $849,800	-20,000 Reduced 37.92%	32,738 $1.22 Million
Q2 2021 Aug 05, 2021	SELL	$29.3 - $44.5 $1,465 - $2,225	-50 Reduced 0.09%	52,738 $2.15 Million
Q3 2020 Oct 21, 2020	BUY	$17.61 - $31.86 $91,572 - $165,672	5,200 Added 10.93%	52,788 $1.36 Million
Q1 2020 Apr 16, 2020	BUY	$12.31 - $33.12 $61,550 - $165,600	5,000 Added 11.74%	47,588 $731,000
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $72,600 - $384,900	-10,000 Reduced 19.02%	42,588 $1.46 Million
Q1 2019 May 14, 2019	BUY	$10.9 - $14.09 $5,755 - $7,439	528 Added 1.01%	52,588 $641,000
Q4 2018 Feb 14, 2019	SELL	$10.36 - $20.96 $20,720 - $41,920	-2,000 Reduced 3.7%	52,060 $593,000
Q4 2017 Jan 10, 2018	BUY	$14.27 - $16.79 $542,260 - $638,020	38,000 Added 236.61%	54,060 $783,000
Q3 2017 Oct 11, 2017	BUY	$10.77 - $22.1 $172,966 - $354,926	16,060	16,060 $253,000

Others Institutions Holding ITCI

# of Institutions

400

Shares Held

87.2M

Call Options Held

309K

Put Options Held

302K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.84B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.

Account

Franklin Street Advisors Inc Intra Cellular Therapies, Inc. Transaction History